Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Bradenton, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Sarkis Clinical Trials
mi
from
Gainesville, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Suncoast Clinical Research, Inc.
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
mi
from
Orlando, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Psychiatric Inst of Florida-Clinical Neuroscience Solutions
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Compass Research
mi
from
Oviedo, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Compass Research
mi
from
Oviedo, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Accord Clinical Research
mi
from
Port Orange, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Roskamp Institute
mi
from
Sarasota, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Roskamp Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Reserach . LLC
mi
from
Sunrise, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Reserach . LLC
mi
from
Sunrise, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Network - Blue Island
mi
from
Blue Island, IL
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Network - Blue Island
mi
from
Blue Island, IL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Investigative Clinical Research of Indiana, LLC
mi
from
Elwood, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Investigative Clinical Research of Indiana, LLC
mi
from
Elwood, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Deaconess Clinic
mi
from
Newburgh, IN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Deaconess Clinic
mi
from
Newburgh, IN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Integrated Clinical Trial Services, Inc.
mi
from
West Des Moines, IA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Integrated Clinical Trial Services, Inc.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Phoenix Medical Research
mi
from
Prairie Village, KA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Phoenix Medical Research
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Otri-Med Corporation
mi
from
Edgewood, KY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Otri-Med Corporation
mi
from
Edgewood, KY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
L-MARC Research Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Pharmasite Research
mi
from
Baltimore, MD
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Pharmasite Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Institute Inc.
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinvest
mi
from
Springfield, MO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinvest
mi
from
Springfield, MO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
mi
from
Nashua, NH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthy Perspectives Innovative Mental Health Services, PL
mi
from
Nashua, NH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Dent Neurological Institute
mi
from
Amherst, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Dent Neurological Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Central New York Clinical Research
mi
from
Manlius, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Central New York Clinical Research
mi
from
Manlius, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone
mi
from
New York, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Fieve Clincial Services
mi
from
New York, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Fieve Clincial Services
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Metrolina Neurological Associates, PA
mi
from
Charlotte, NC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Metrolina Neurological Associates, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Medical College of Ohio at Toledo
mi
from
Toledo, OH
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Medical College of Ohio at Toledo
mi
from
Toledo, OH
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Healthcare Research Consultant
mi
from
Tulsa, OK
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Healthcare Research Consultant
mi
from
Tulsa, OK
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Summit Research Network
mi
from
Portland, OR
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Lehigh Center for Clinical Research
mi
from
Allentown, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Preferred Primary Care Physicians, Inc
mi
from
Pittsburgh, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Preferred Primary Care Physicians, Inc
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
mi
from
Willow Grove, PA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of South Carolina
mi
from
Charleston, SC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
8 Medical Park
mi
from
Columbia, SC
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
8 Medical Park
mi
from
Columbia, SC
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
University of Tennessee Medical Center
mi
from
Knoxville, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
FutureSearch Trials
mi
from
Austin, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Protenium Clinical Research
mi
from
Hurst, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Protenium Clinical Research
mi
from
Hurst, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Radiant Research - San Antonio
mi
from
San Antonio, TX
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Radiant Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials